Biocon up 5 per cent as Malaysia arm gets GMP compliance certificate Ruby Khatun Khatun10 Sept 2017 11:19 AM ISTNew Delhi: Shares of biopharmaceutical firm Biocon surged over 5 per cent after the company said its Malaysian arm Biocon Sdn Bhd has received EU GMP...
Novartis hopeful for novel heart drug, despite modest benefit Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTZURICH: Novartis will seek regulatory approval this year for a new kind of anti-inflammatory heart drug, though some experts fear fatal infection...
Europe ready to embrace first copies of biotech cancer drugs supriya kashyap kashyap17 Feb 2017 12:25 PM ISTLondon : Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche's blood cancer drug Rituxan...